[{"address1": "1111 Main Street", "address2": "Suite 660", "city": "Vancouver", "state": "WA", "zip": "98660", "country": "United States", "phone": "360 980 8524", "fax": "360 799 5954", "website": "https://www.cytodyn.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CytoDyn Inc., a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Dr. Cyrus  Arman M.B.A., Ph.D.", "age": 41, "title": "Senior Vice President of Business Operations", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 451170, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jacob P. Lalezari M.D.", "age": 63, "title": "CEO & Member of Scientific Advisory Board", "yearBorn": 1960, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mitchell  Cohen", "age": 66, "title": "Interim Chief Financial Officer", "yearBorn": 1957, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Tyler  Blok", "age": 35, "title": "Executive Vice President of Legal Affairs & Secretary", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott  Hansen Ph.D.", "title": "Head of Research & Basic Science", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Joseph  Meidling", "title": "Executive Director of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Cristina  De Leon", "title": "Investors", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.181, "open": 0.188, "dayLow": 0.181, "dayHigh": 0.1985, "regularMarketPreviousClose": 0.181, "regularMarketOpen": 0.188, "regularMarketDayLow": 0.181, "regularMarketDayHigh": 0.1985, "beta": 0.205, "forwardPE": -1.0446666, "volume": 3964894, "regularMarketVolume": 3964894, "averageVolume": 3575500, "averageVolume10days": 5423000, "averageDailyVolume10Day": 5423000, "marketCap": 185418352, "fiftyTwoWeekLow": 0.15, "fiftyTwoWeekHigh": 0.42, "fiftyDayAverage": 0.1838, "twoHundredDayAverage": 0.20735, "currency": "USD", "enterpriseValue": 217226960, "floatShares": 966258000, "sharesOutstanding": 986057984, "heldPercentInsiders": 0.008090001, "heldPercentInstitutions": 0.00022, "impliedSharesOutstanding": 979526976, "bookValue": -0.118, "lastFiscalYearEnd": 1685491200, "nextFiscalYearEnd": 1717113600, "mostRecentQuarter": 1701302400, "netIncomeToCommon": -55075000, "trailingEps": -0.05, "forwardEps": -0.18, "enterpriseToEbitda": -13.862, "52WeekChange": -0.5263158, "SandP52WeekChange": 0.33757293, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "CYDY", "underlyingSymbol": "CYDY", "shortName": "CYTODYN INC", "longName": "CytoDyn Inc.", "firstTradeDateEpochUtc": 1166020200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "b264fe39-7e85-3dca-b7e0-99a5207f5fa1", "messageBoardId": "finmb_10039157", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.18804, "recommendationMean": 3.0, "recommendationKey": "hold", "totalCash": 147000, "ebitda": -15671000, "totalDebt": 33267000, "quickRatio": 0.001, "currentRatio": 0.072, "returnOnAssets": -1.2038, "freeCashflow": -11323000, "operatingCashflow": -16627000, "financialCurrency": "USD", "trailingPegRatio": null}]